2m 2m 2m 2m 2m 2m 2m
Jade Biosciences (JBIO)
NASDAQ
$21.35+$0.01 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.4BMarket Cap
- 159.30%1-Year Change
- BiotechnologyIndustry
Jade Biosciences (JBIO)
$21.35+$0.01 (+0.05%)
JBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.34 | ||
Change | +$0.11 (+0.52%) | ||
Open | $21.45 | ||
High | $22.12 | ||
Low | $21.13 | ||
Previous Close | $21.23 | ||
Volume | 571,848 | ||
30-Day Average Volume | 827,765 | ||
1-Week Change | -13.64% | ||
1-Month Change | 3.95% | ||
1-Year Change | 159.30% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 63.6M | ||
Total Assets | $472.1M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | -$245,000.00 | ||
Net Income | -$55.8M | ||
Free Cash Flow | -$43.7M | ||
EBIT | -$55.8M | ||
EBITDA | -$55.7M | ||
Net Working Capital | $439.7M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | -5,102 | ||
P/B | 3 | ||
P/E | -28 | ||
PEG | 1 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue